TY - JOUR
T1 - Prevalence of cardio-metabolic syndrome in Nigeria
T2 - A systematic review
AU - Oguoma, Victor
AU - Nwose, Ezekiel Uba
AU - Richards, R. S.
PY - 2015/5
Y1 - 2015/5
N2 - Objective: This is a systematic review of the distribution of cardiometabolic syndrome (CMS) in Nigeria, the clinical definitions widely used and how it affects the proposition of a national prevalence of CMS that will advise management interventions. Study design: Systematic review of literature. Methods: To present a comprehensive report of the distribution of CMS in Nigeria, extensive searches was carried out on PubMed, African Journals Online (AJOL), SCOPUS, EBSCOhost (CINAHL Plus), Google Scholar and Science Direct using terms: Nigeria, metabolic syndrome, cardio-metabolic syndrome, syndrome X, World Health Organization, International Diabetic Federation, National Cholesterol Education Program Adult Treatment Panel III, European Group for study on Insulin Resistance, American Association of Clinical Endocrinologist, American Heart Association/National Heart, Lung and Blood Institute. All published data between January 2002 and December 2013 were collated into a database. Information gathered and recorded for each source were the population sampled, age and number of population, locality, clinical definition used, longitude and latitude, and period of the study. Results: Out of 32 studies, 9 (28.1%) adopted the WHO classification, 19 (59.4%) used the ATPIII definition, while the remaining 10 (31.3%) studies used the IDF definitions. Twenty (62.5%) were hospital-based studies on diabetic, hypertensive, HIV, asthmatic and thyroid disorder patients. The remaining 12 (37.5%) studies were population-based studies in urban, suburb and rural settings. The mean overall prevalence of CMS in Nigeria is 31.7%, 27.9% and 28.1% according to the WHO, ATPIII and IDF definitions, respectively. Most of the studies were from the Southern region. Age groups mostly studied were those from ≥35years. Conclusion: The report of this review provides an essential overview on the current distribution of CMS in Nigeria. It provides an insight to direct future studies such as the need to (1) study rural communities where lifestyles are not westernized as in the urban areas, and (2) young adults, as well as (3) develop a consensus on the definition of CMS among the Sub-Saharan African populations.
AB - Objective: This is a systematic review of the distribution of cardiometabolic syndrome (CMS) in Nigeria, the clinical definitions widely used and how it affects the proposition of a national prevalence of CMS that will advise management interventions. Study design: Systematic review of literature. Methods: To present a comprehensive report of the distribution of CMS in Nigeria, extensive searches was carried out on PubMed, African Journals Online (AJOL), SCOPUS, EBSCOhost (CINAHL Plus), Google Scholar and Science Direct using terms: Nigeria, metabolic syndrome, cardio-metabolic syndrome, syndrome X, World Health Organization, International Diabetic Federation, National Cholesterol Education Program Adult Treatment Panel III, European Group for study on Insulin Resistance, American Association of Clinical Endocrinologist, American Heart Association/National Heart, Lung and Blood Institute. All published data between January 2002 and December 2013 were collated into a database. Information gathered and recorded for each source were the population sampled, age and number of population, locality, clinical definition used, longitude and latitude, and period of the study. Results: Out of 32 studies, 9 (28.1%) adopted the WHO classification, 19 (59.4%) used the ATPIII definition, while the remaining 10 (31.3%) studies used the IDF definitions. Twenty (62.5%) were hospital-based studies on diabetic, hypertensive, HIV, asthmatic and thyroid disorder patients. The remaining 12 (37.5%) studies were population-based studies in urban, suburb and rural settings. The mean overall prevalence of CMS in Nigeria is 31.7%, 27.9% and 28.1% according to the WHO, ATPIII and IDF definitions, respectively. Most of the studies were from the Southern region. Age groups mostly studied were those from ≥35years. Conclusion: The report of this review provides an essential overview on the current distribution of CMS in Nigeria. It provides an insight to direct future studies such as the need to (1) study rural communities where lifestyles are not westernized as in the urban areas, and (2) young adults, as well as (3) develop a consensus on the definition of CMS among the Sub-Saharan African populations.
KW - asthma
KW - diabetes
KW - disease prevalence
KW - disease severity
KW - geographical distribution
KW - human immunodeficiency virus
KW - hypertension
KW - lifestyle
KW - metabolism
KW - rural area
KW - urban area
KW - World Health Organization
KW - age distribution
KW - cardiometabolic syndrome
KW - data analysis
KW - diabetes mellitus
KW - disease association
KW - human
KW - Human immunodeficiency virus infection
KW - medical service
KW - medical society
KW - metabolic syndrome X
KW - Nigeria
KW - outcome assessment
KW - prevalence
KW - Review
KW - syndrome delineation
KW - syndrome X
KW - systematic review
KW - thyroid disease
KW - Cardiovascular Diseases
KW - Humans
KW - Metabolic Syndrome X
KW - Prevalence
UR - http://www.scopus.com/inward/record.url?scp=84930276746&partnerID=8YFLogxK
U2 - 10.1016/j.puhe.2015.01.017
DO - 10.1016/j.puhe.2015.01.017
M3 - Review article
C2 - 25736900
SN - 0033-3506
VL - 129
SP - 413
EP - 423
JO - Public Health
JF - Public Health
IS - 5
ER -